We found that IL-15 expression was significantly higher in the hepatic mononuclear cells from participants with NASH or liver cirrhosis than in those from controls, but IL18 expression did not significantly differ among the three groups (Fig. 3d). This evidence concerns the gene IL15 and metabolic dysfunction-associated steatohepatitis.